Oruka Therapeutics Inc
NASDAQ:ORKA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
US |
|
Encres Dubuit SA
PAR:ALDUB
|
FR |
|
P
|
Pan American Silver Corp
XMUN:PA2
|
CA |
|
S
|
Showa Denko KK
F:SWD
|
JP |
|
L
|
Leonardo SpA
XMUN:FMNB
|
IT |
|
L
|
Lloyds Banking Group PLC
DUS:LLD
|
UK |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
A
|
Administer Oy
OMXH:ADMIN
|
FI |
Intrinsic Value
The intrinsic value for
Oruka Therapeutics Inc (ORKA) under the Base Case is hidden
USD.
Compared with the current market price of 92.27 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
ORKA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ORKA’s past valuations and how the stock performed after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Oruka Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Oruka Therapeutics Inc
Earnings Waterfall
Oruka Therapeutics Inc
The intrinsic value for
Oruka Therapeutics Inc (ORKA) under the Base Case is hidden USD.
Compared with the current market price of 92.27 USD, the stock appears hidden.